|

Proleukin Clinical Trials

2 actively recruiting trials

Also known as: Interleukin 2

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Inge Marie Svane1
  • Centre Hospitalier St Anne1

Indications

  • Alzheimer's Disease1
  • Melanoma Stage III1
  • Melanoma Stage IV1
  • Alzheimer Disease1
  • Melanoma1

Other2 trials

Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD
Phase 2
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.